← Eichor
Study identifier: NCT06880224 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation Hybrid Study

Condition: Adolescent HIV Infection  ·  Sponsor: Northwestern University

PhaseNA
Planned participants500
Who can joinAll sexes, 15 Years to 24 Years
Healthy volunteersYes

About this study

Two combination interventions (HIV Case Finding Intervention and HIV Treatment Intervention), each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria.

This description comes directly from the study's public registry record.

Talk to the study team

Robert Garofalo, MD  ·  312-227-7740  ·  rgarofalo@luriechildrens.org

Lisa M Kuhns, PhD  ·  312-227-7740  ·  lkuhns@luriechildrens.org

Always discuss trial participation with your own doctor first.

Locations (6)

University of Uyo Teaching HospitalUyo, Akwa Ibom State, NigeriaRecruiting
Federal Medical CenterMakurdi, Benue State, NigeriaRecruiting
Taraba State Specialist HospitalJalingo, Taraba State, NigeriaRecruiting
University of Nigeria Teaching HospitalEnugu, NigeriaRecruiting
Aminu Kano Teaching HospitalKano, NigeriaRecruiting
Lagos University Teaching HospitalLagos, NigeriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06880224